HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
about
Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy.Textile industry manufacturing by-products induce human melanoma cell proliferation via ERK1/2 activation.Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody
P2860
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@ast
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@en
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@nl
type
label
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@ast
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@en
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@nl
prefLabel
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@ast
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@en
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@nl
P2093
P2860
P1433
P1476
HER2 as a promising target for cytotoxicity T cells in human melanoma therapy.
@en
P2093
Changzhen Liu
Hongxiang Feng
Huamin Han
P2860
P304
P356
10.1371/JOURNAL.PONE.0073261
P407
P577
2013-08-27T00:00:00Z